Thorlef Spickschen

Thorlef Spickschen is a declared insider at 2 companies; the most frequent names are Clovis Oncology, Inc. and Pharmion Corp. The record holds 18 filings, for trades running from 7 March 2008 to 16 August 2019.

Both buying and selling appear: 3 purchases worth €217k, against 8 sales worth €1.8M. Netting one side against the other leaves €1.6M of net selling. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The rest of the record consists of 2 option exercises. So far in 2019, the count stands at 2 purchases and no sales.

In size, the median ticket on the buying side is €45k.

The newest entry dates from 16 August 2019: an open-market purchase of €44k, in Clovis Oncology, Inc. Most trades are made public on the day they happen. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.